HealthEquity (NASDAQ:HQY) Price Target Cut to $110.00 by Analysts at KeyCorp

HealthEquity (NASDAQ:HQY) had its target price cut by KeyCorp from $120.00 to $110.00 in a research note published on Monday,Benzinga reports. They currently have an overweight rating on the stock.

Other equities research analysts also recently issued reports about the company. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Barrington Research reiterated an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, March 14th. Wells Fargo & Company upped their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $113.69.

HealthEquity Price Performance

NASDAQ HQY opened at $90.32 on Monday. The stock has a market capitalization of $7.81 billion, a price-to-earnings ratio of 82.86, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The business’s fifty day moving average price is $104.67 and its 200-day moving average price is $95.84.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 2.20% of the stock is owned by insiders.

Institutional Trading of HealthEquity

Hedge funds have recently made changes to their positions in the business. Wealthfront Advisers LLC purchased a new stake in shares of HealthEquity during the fourth quarter valued at $10,304,089,000. Vanguard Group Inc. lifted its position in HealthEquity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after acquiring an additional 99,624 shares during the last quarter. Wasatch Advisors LP boosted its position in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares in the last quarter. FMR LLC boosted its holdings in HealthEquity by 2.4% in the fourth quarter. FMR LLC now owns 5,415,800 shares of the company’s stock worth $519,646,000 after acquiring an additional 125,684 shares in the last quarter. Finally, State Street Corp grew its position in HealthEquity by 0.8% during the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.